Amber Ghaddar – Global DCA

Amber Ghaddar

Amber Ghaddar

Founder at AllianceBlock

  • Founder of AllianceBlock – which is simplifying capital markets by building a decentralized finance ecosystem

  • Founder of The 200 Billion Club which aims to add £200Bn to the UK economy by financing women led startups

  • Former bond trader at JP Morgan London – holding various leadership positions

Amber Ghaddar is the Founder of AllianceBlock – which is simplifying capital markets by building a Decentralized Finance Ecosystem.
The ecosystem collapses multiple layers of traditional investment banking in order to streamline Issuance, Validation and Governance while integrating a unique Cross Border Regulatory and Compliance Framework. Amber is also Founder of The 200 Billion Club which aims to add £200Bn to the UK economy by financing women led startups. With more than 40VC partners, she aims to change the investment paradigm within venture capital.

Prior to Allianceblock and The 200 Billion Club, Amber was a bond trader at JP Morgan London where she held various leadership positions.

Amber started her career in Global Investment Research at Goldman Sachs London, and moved from there to the Cross Asset Solution team at JP Morgan London in 2012, where she worked on structured and exotic products across Equities, FX, Rates, Credit and Commodities. She then, spearheaded the Macro Systematic Trading Strategies effort at JP Morgan London, focusing on fixed income dynamic risk premia trading strategies.

Amber is one of the masterminds behind participative capitalism and calibrocracy, and has been invited to world class events (Davos, TEDx, UN Women, Money2020 …) to give talks on the subject. She is a guest lecturer at EDHEC in Nice. She has been featured in the Women in Crypto Powerlist 2020 by the Fintech Times and is a recognized voice in the field where she’s been quoted on Bloomberg, Forbes, Nasdaq and other media.

Amber holds a B.Sc in Science & Technology, Three Masters (Neurosciences, Microelectronics & Nanotechnologies, and International Business) and a PhD in Molecular Medicine. She is a graduate of McGill Canada and HEC Paris.